US3097202A - 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin - Google Patents
3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin Download PDFInfo
- Publication number
- US3097202A US3097202A US78315A US7831560A US3097202A US 3097202 A US3097202 A US 3097202A US 78315 A US78315 A US 78315A US 7831560 A US7831560 A US 7831560A US 3097202 A US3097202 A US 3097202A
- Authority
- US
- United States
- Prior art keywords
- ethyl
- nitrofurfurylideneamino
- pyridyl
- hydantoin
- acetonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Definitions
- This invention relates to 1-(5-nitrofurfurylideneamino) hydantoins substituted in the 3-position of the hydantoin nucleus which may be represented by the formula:
- R represents a member of the group consisting of acetonyl, hydroxyethyl and 2-(4-pyridy1)ethyl.
- hydantoins are highly effective, relatively nontoxic systemic antimicrobial agents. They control systemic infections in animals caused by microorganisms such as Staphylococcus aureus and Eimeria tenella. Mice lethally infected with S. aureus are protected by the peroral administration of a single dose of from 105-210 mg./ kg. of these compounds given post infection as a suspension in carboxylmethylcellulose. Chickens infected with E. tenella are protected against the morbidity and mortality associated with coccidiosis provoked by that organism through the administration of these compounds incorporated in their feed at a level of 0.022% by weight.
- mice tolerable doses of these compounds range from 7702200 mg./kg. In chickens no evidence of toxic side elfect is seen at the level employed to combat coccidiosis.
- the methods which I have employed for the production of these compounds involve reacting a l-(alkylideneamino)hydantoin or a salt thereof with a compound containing a functional unit to introduce the substituent above defined as R and treating the formed 3-R-substituted-l-(alkylideneamino)hydantoin under hydrolytic conditions if necessary to free the 3-R-substituted-1-aminohydantoin for reaction with 5-nitro-2-furaldehyde or a derivative thereof hydrolyzable thereto.
- a representative schema In order to convert the I i-substituted-l-(alkylideneamino) hydantoins depicted in the above representative schema (I and II) to the desired S-nitro furfurylidene compound, I have found it to be advantageous to hydrolyze them in an acidified aqueous medium such as aqueous mineral acid under the influence of heat and to add 5- nitrofuraldehyde or an equivalent thereof, such as S-nitrofuraldehyde diacetate which is readily hydrolyzed under the reaction conditions, to the medium. Where the alkylidene component is volatile, steam distillation in the presence of acid is an effective means for removing the volatile component from the reaction mixture and at the same time effecting hydrolysis.
- 5-nitro-2-furaldehyde diaoetate may be used accompanied by heating to effect its hydrolysis.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1310188D FR1310188A (no) | 1960-12-27 | ||
US78315A US3097202A (en) | 1960-12-27 | 1960-12-27 | 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin |
DEN20886A DE1147589B (de) | 1960-12-27 | 1961-11-29 | Verfahren zur Herstellung von bakterizid wirksamen, in 3-Stellung substituierten Derivaten des 1-(5-Nitrofurfuryliden-amino)-hydantoins |
DEN20887A DE1147590B (de) | 1960-12-27 | 1961-11-29 | Verfahren zur Herstellung von bakterizid wirksamen, in 3-Stellung substituierten Derivaten des 1-(5-Nitrofurfuryliden-amino)-hydantoins |
CH667866A CH416652A (de) | 1960-12-27 | 1961-12-06 | Verfahren zur Herstellung von 3-Acetonyl-1-(5-nitrofurfuryliden-amino)-hydantoin |
GB43775/61A GB1002644A (en) | 1960-12-27 | 1961-12-06 | Improvements in or relating to nitrofurfurylideneamino hydantoins |
CH1413961A CH414651A (de) | 1960-12-27 | 1961-12-06 | Verfahren zur Herstellung von 3-(2-Hydroxyäthyl)-1-(5-nitro-furfuryliden-amino)-hydantoin |
CH1528665A CH411909A (de) | 1960-12-27 | 1961-12-06 | Verfahren zur Herstellung eines neuen in 3-Stellung substituierten Derivates des 1-(5-Nitrofurfurylidenamino)-hydantoins |
SE12807/61A SE300107B (no) | 1960-12-27 | 1961-12-21 | |
FR882730A FR1706M (fr) | 1960-12-27 | 1961-12-21 | Nouveaux composés antistaphylococciques de la série de l'hydantoine. |
BE611940D BE611940A (no) | 1960-12-27 | 1961-12-22 | |
ES0273245A ES273245A1 (es) | 1960-12-27 | 1961-12-26 | Un metodo de preparar un compuesto representado por la fërmula.. |
BR135262/61A BR6135262D0 (pt) | 1960-12-27 | 1961-12-26 | Processo para a preparacao de 1-(5-nitrofur-furilideneamino) hidantoinas substituidas na posicao 3 do nucleo hidantoina |
NL272956D NL272956A (no) | 1960-12-27 | 1961-12-27 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78315A US3097202A (en) | 1960-12-27 | 1960-12-27 | 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin |
Publications (1)
Publication Number | Publication Date |
---|---|
US3097202A true US3097202A (en) | 1963-07-09 |
Family
ID=22143260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US78315A Expired - Lifetime US3097202A (en) | 1960-12-27 | 1960-12-27 | 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin |
Country Status (10)
Country | Link |
---|---|
US (1) | US3097202A (no) |
BE (1) | BE611940A (no) |
BR (1) | BR6135262D0 (no) |
CH (3) | CH414651A (no) |
DE (2) | DE1147590B (no) |
ES (1) | ES273245A1 (no) |
FR (2) | FR1706M (no) |
GB (1) | GB1002644A (no) |
NL (1) | NL272956A (no) |
SE (1) | SE300107B (no) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3386995A (en) * | 1964-06-18 | 1968-06-04 | Norwich Pharma Co | 1-substituted-3-(5-nitrofurfurylidene-amino)-2-imidazolidinones |
US3446802A (en) * | 1960-12-27 | 1969-05-27 | Norwich Pharma Co | 3-hydroxymethyl-1-(5-nitrofurfurylideneamino) hydantoin |
WO1993004061A1 (en) * | 1991-08-14 | 1993-03-04 | Procter & Gamble Pharmaceuticals | Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3415821A (en) * | 1965-09-07 | 1968-12-10 | Norwich Pharma Co | 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990402A (en) * | 1958-10-07 | 1961-06-27 | Smith Kline French Lab | Preparation of 1-aminohydantoin derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL253959A (no) * | 1959-11-27 |
-
0
- FR FR1310188D patent/FR1310188A/fr not_active Expired
-
1960
- 1960-12-27 US US78315A patent/US3097202A/en not_active Expired - Lifetime
-
1961
- 1961-11-29 DE DEN20887A patent/DE1147590B/de active Pending
- 1961-11-29 DE DEN20886A patent/DE1147589B/de active Pending
- 1961-12-06 CH CH1413961A patent/CH414651A/de unknown
- 1961-12-06 GB GB43775/61A patent/GB1002644A/en not_active Expired
- 1961-12-06 CH CH667866A patent/CH416652A/de unknown
- 1961-12-06 CH CH1528665A patent/CH411909A/de unknown
- 1961-12-21 SE SE12807/61A patent/SE300107B/xx unknown
- 1961-12-21 FR FR882730A patent/FR1706M/fr not_active Expired
- 1961-12-22 BE BE611940D patent/BE611940A/xx unknown
- 1961-12-26 BR BR135262/61A patent/BR6135262D0/pt unknown
- 1961-12-26 ES ES0273245A patent/ES273245A1/es not_active Expired
- 1961-12-27 NL NL272956D patent/NL272956A/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990402A (en) * | 1958-10-07 | 1961-06-27 | Smith Kline French Lab | Preparation of 1-aminohydantoin derivatives |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3446802A (en) * | 1960-12-27 | 1969-05-27 | Norwich Pharma Co | 3-hydroxymethyl-1-(5-nitrofurfurylideneamino) hydantoin |
US3386995A (en) * | 1964-06-18 | 1968-06-04 | Norwich Pharma Co | 1-substituted-3-(5-nitrofurfurylidene-amino)-2-imidazolidinones |
WO1993004061A1 (en) * | 1991-08-14 | 1993-03-04 | Procter & Gamble Pharmaceuticals | Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
Also Published As
Publication number | Publication date |
---|---|
SE300107B (no) | 1968-04-08 |
DE1147590B (de) | 1963-04-25 |
CH414651A (de) | 1966-06-15 |
FR1310188A (no) | 1963-03-06 |
CH411909A (de) | 1966-04-30 |
BE611940A (no) | 1962-04-16 |
BR6135262D0 (pt) | 1973-05-24 |
DE1147589B (de) | 1963-04-25 |
GB1002644A (en) | 1965-08-25 |
CH416652A (de) | 1966-07-15 |
ES273245A1 (es) | 1962-05-01 |
NL272956A (no) | 1964-08-25 |
FR1706M (fr) | 1963-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69721526T2 (de) | Benzofuran carboxamide und ihre therapeutische anwendung | |
DE3531487C2 (de) | Benzimidazolderivate | |
DE2915037C3 (de) | Neue N-substituierte Moranolinderivate | |
AU597696B2 (en) | Benzimidazole derivatives | |
FR2643903A1 (fr) | Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux | |
CH624395A5 (no) | ||
DE3906920A1 (de) | Piperazinderivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische mittel mit einem gehalt derselben als wirkstoff | |
CH648553A5 (de) | Neue 3,4-dihydro-5h-2,3-benzodiazepin-derivate und verfahren zur herstellung derselben. | |
DE3007006C2 (de) | Chinoloncarbonsäurederivate, deren Salze, Verfahren zu deren Herstellung und diese Derivate enthaltende Mittel | |
DE1922003A1 (de) | Aminosaeure-Derivate und Verfahren zur Herstellung derselben | |
EP0096296A2 (de) | 1-Sulfo-2-oxoazetidinderivate | |
US3097202A (en) | 3-[acetonyl; hydroxyethyl; and 2-(4-pyridyl)-ethyl]-1-(5-nitrofurfurylideneamino) hydntoin | |
CH641757A5 (en) | O-Alkylated hydroxylamines and process for the preparation thereof | |
CH636099A5 (de) | Verfahren zur herstellung von piperidinopropanolderivaten. | |
DE3927930A1 (de) | Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate | |
US3060177A (en) | O-(aminoalkyl)oxime derivatives of heterocyclic aldehydes and ketones | |
DE3739882A1 (de) | Substituierte hydroxylamine | |
NO142647B (no) | Fremgangsmaate for fremstilling av smoerbare vann-i-olje-emulsjoner med lavt fettinnhold | |
DE1164416B (de) | Verfahren zur Herstellung von in 3-Stellung aminoalkylierten Derivaten des 1-(5-Nitrofurfuryliden-amino)-hydantoins und ihren Salzen | |
DE3027106C2 (no) | ||
CH509318A (de) | Verfahren zur Herstellung von substituierten Benzimidazolen | |
DE1695560C3 (de) | Pyrid-2-thione und diese enthaltende pharmazeutische Zusammensetzungen | |
DE3603362A1 (de) | In 2-stellung substituierte cycloheptoimidazolverbindungen, ihre herstellung und sie enthaltendes arzneimittel | |
DE19539091A1 (de) | 5-gliedrige Heterocyclen, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zur ihrer Herstellung | |
US2975185A (en) | Piperidinol compounds |